Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery.
Sevag Demirjian, C Allen Bashour, Andrew Shaw...
https://pubmed.ncbi.nlm.nih.gov/35258532Actively Recruiting
Led by University of Colorado, Denver · Updated on 2025-05-21
1100
Participants Needed
1
Research Sites
26 weeks
Total Duration
U
University of Colorado, Denver
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
Researchers are evaluating the effectiveness of pulsatile blood flow during cardiopulmonary bypass to reduce the risk of acute kidney injury following cardiac surgery. Pulsatile flow mimics the natural pulse of a beating heart, compared to non-pulsatile flow which provides a constant blood flow. The study aims to compare these two methods to see if pulsatile flow improves clinical outcomes after surgery, particularly kidney health. Participants will be randomly assigned to receive either pulsatile or non-pulsatile blood flow during their cardiopulmonary bypass procedure. Both methods are standard care approaches used to maintain blood circulation while the heart is stopped during surgery. Pulsatile flow is generated by varying the pump rate to create pulses, while non-pulsatile flow uses a constant pump rate. The study does not involve masking or blinding. During the study, participants will be monitored from the time they enter the intensive care unit after surgery for up to seven days to assess kidney injury and other outcomes. Researchers will track acute kidney injury, blood transfusions, platelet counts, and mortality up to 30 days after surgery. The study will also observe the use and discontinuation of bypass modes and monitor safety. The total participation timeline includes the surgery and follow-up assessments in the hospital.
CONDITIONS
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and up to 7 days post-surgery
Participants undergo cardiac surgery with cardiopulmonary bypass using either pulsatile or non-pulsatile blood flow during the procedure.
Monitoring during surgery and intensive care unit stay
Duration - Up to 30 days after surgery
Participants are monitored for acute kidney injury and other outcomes after surgery until hospital discharge or up to 30 days.
Visits during intensive care unit stay and hospital discharge assessments
Total: 1 location
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045
Actively Recruiting
N
Nathan J Clendenen, MD,MS
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sevag Demirjian, C Allen Bashour, Andrew Shaw...
https://pubmed.ncbi.nlm.nih.gov/35258532Arif Khwaja
https://pubmed.ncbi.nlm.nih.gov/22890468Aileen Tan, Caroline Newey, Florian Falter
https://pubmed.ncbi.nlm.nih.gov/36380831